Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. (2015)
Attributed to:
Effective and efficient conduct of trials and meta-analyses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/hiv.12230
PubMed Identifier: 25711320
Publication URI: http://europepmc.org/abstract/MED/25711320
Type: Journal Article/Review
Volume: 16 Suppl 1
Parent Publication: HIV medicine
Issue: 0 1
ISSN: 1464-2662